Related Experiment Videos
Mode of action of gentamicin antibiotics produced by Micromonospora purpurea
Abstract:
Gentamicin antibiotics were produced fermentatively by Micromonospora purpurea. They were separated into gentamicin C1, C1a and C2 by paper chromatographic technique, using chloroform, methanol, and 17.0% of NH4OH (2: 1: 1 v/v) as developing solvent. The different antibiotics showed variable antimicrobial activities. The gentamicin antibiotics inhibited the biosynthesis of DNA and RNA of the proteins, present in the cells of Staphylococcus aureus.
Insights
Gentamicin antibiotics, produced by Micromonospora purpurea, were separated and tested against Staphylococcus aureus. These antibiotics were found to inhibit the biosynthesis of DNA, RNA, and proteins in bacterial cells.
Area of Science:
- Microbiology
- Biochemistry
- Pharmacology
Background:
- Gentamicin is a crucial antibiotic produced by Micromonospora purpurea.
- Understanding the separation and antimicrobial mechanisms of gentamicin components is vital for effective therapeutic use.
Purpose of the Study:
- To fermentatively produce gentamicin antibiotics using Micromonospora purpurea.
- To separate gentamicin into its components: C1, C1a, and C2.
- To investigate the antimicrobial activities and cellular targets of these gentamicin components against Staphylococcus aureus.
Main Methods:
- Fermentative production of gentamicin by Micromonospora purpurea.
- Paper chromatography using a specific solvent system (chloroform: methanol: 17.0% NH4OH, 2:1:1 v/v) for antibiotic separation.
- Assessment of variable antimicrobial activities of separated gentamicin components.
- Determination of gentamicin's effect on DNA, RNA, and protein biosynthesis in Staphylococcus aureus cells.
Main Results:
- Successful fermentative production and separation of gentamicin C1, C1a, and C2.
- Demonstration of variable antimicrobial activities among the different gentamicin components.
- Identification of gentamicin's inhibitory effect on DNA, RNA, and protein biosynthesis in Staphylococcus aureus.
Conclusions:
- Micromonospora purpurea is an effective source for gentamicin production.
- The separated gentamicin components exhibit distinct antimicrobial properties.
- Gentamicin exerts its antibacterial effect by disrupting essential cellular processes like DNA, RNA, and protein synthesis in Staphylococcus aureus.